Updated:
AmpliPhi Biosciences Corporation
AmpliPhi Biosciences Corporation is a San Diego-based biotechnology investment firm with limited public disclosure on team, AUM, or portfolio.
AmpliPhi Biosciences Corporation
AmpliPhi Biosciences Corporation was established to invest in biotechnology and healthcare companies, though its founding year and founding principal are not publicly documented. The firm's headquarters is listed in San Diego, California, but prior addresses span multiple US states and international locations, suggesting a complex corporate history. Strategy and deployment center on the biotechnology sector, with a focus on early-stage and growth-stage opportunities. The firm likely engages in direct investments and co-investments, but no specific portfolio companies or deal partners are confirmed in public records. Geographic focus appears to be domestic United States, with no disclosed international activity. The firm's scale is unknown, with no public information on team size, additional offices, or AUM. Adjacent vehicles such as philanthropic foundations or operating companies have not been identified. No recent operational events from the last 24 months are available in public sources. A structural differentiator for AmpliPhi is its apparent operation as a corporate entity with ties to biotechnology, possibly indicating an operating-company model that invests in or acquires related technologies. However, the lack of transparency makes it difficult to assess governance or succession structures.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Diego
Corporate office
San Diego, CA, United States
Sector focus
Frequently asked questions
Who runs investment decisions at AmpliPhi Biosciences Corporation?
No named principals or investment committee members are publicly disclosed for AmpliPhi Biosciences Corporation. The firm does not provide leadership details on its website or in public filings, making it unclear who controls investment decisions.
How does AmpliPhi Biosciences Corporation source deal flow?
Deal flow sourcing mechanisms are not publicly described. As a biotechnology-focused investment entity, the firm may rely on internal scientific expertise or industry networks, but no specific sourcing model has been disclosed.
Is AmpliPhi Biosciences Corporation structured as a single family office or does it operate more like a venture firm?
The firm's structure is undefined in public records. Its website redirects to Targen.com, which provides no investment or team information, leaving the operational model ambiguous. It may function as a corporate venture arm or a family office with biotechnology specialization.
Does AmpliPhi Biosciences Corporation participate in fund commitments or only direct deals?
No information is available on whether the firm commits to external funds or executes direct investments exclusively. Public records do not list any fund positions or direct portfolio holdings.
What investment stages does AmpliPhi Biosciences Corporation typically target?
Based on the firm's biotechnology focus, it likely targets early-stage and growth-stage companies, but no specific stage preferences or check sizes are documented in public sources.
Where does the underlying wealth come from for AmpliPhi Biosciences Corporation?
The origin of capital for AmpliPhi Biosciences Corporation is not disclosed. It may be funded by a single family or a group of investors, but no wealth origin details are publicly available.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: